Baicalin and baicalein from Scutellaria baicalensis Georgi alleviate aberrant neuronal suppression mediated by GABA from reactive astrocytes

Abstract

AbstractAimsγ‐aminobutyric acid (GABA) from reactive astrocytes is critical for the dysregulation of neuronal activity in various neuroinflammatory conditions. While Scutellaria baicalensis Georgi (S. baicalensis) is known for its efficacy in addressing neurological symptoms, its potential to reduce GABA synthesis in reactive astrocytes and the associated neuronal suppression remains unclear. This study focuses on the inhibitory action of monoamine oxidase B (MAO‐B), the key enzyme for astrocytic GABA synthesis.MethodsUsing a lipopolysaccharide (LPS)‐induced neuroinflammation mouse model, we conducted immunohistochemistry to assess the effect of S. baicalensis on astrocyte reactivity and its GABA synthesis. High‐performance liquid chromatography was performed to reveal the major compounds of S. baicalensis, the effects of which on MAO‐B inhibition, astrocyte reactivity, and tonic inhibition in hippocampal neurons were validated by MAO‐B activity assay, qRT‐PCR, and whole‐cell patch‐clamp.ResultsThe ethanolic extract of S. baicalensis ameliorated astrocyte reactivity and reduced excessive astrocytic GABA content in the CA1 hippocampus. Baicalin and baicalein exhibited significant MAO‐B inhibition potential. These two compounds downregulate the mRNA levels of genes associated with reactive astrogliosis or astrocytic GABA synthesis. Additionally, LPS‐induced aberrant tonic inhibition was reversed by both S. baicalensis extract and its key compounds.ConclusionsIn summary, baicalin and baicalein isolated from S. baicalensis reduce astrocyte reactivity and alleviate aberrant tonic inhibition of hippocampal neurons during neuroinflammation.